Lineage Cell Therapeutics, Inc.
NYSE · Healthcare · Biological Products, (No Diagnostic Substances) · Carlsbad, CA
LCTX chart
What traders are saying about $LCTX
Latest postsLineage Cell Therapeutics, Inc. news
- Lineage Cell Therapeutics, Inc. 2Q 2026: Revenue $1.07M, EPS $(0.03) — 10-Q Summary
TradingView ·
- Lineage Cell Therapeutics Stock Price Forecast. Should You Buy LCTX?
StockInvest.us ·
- Press Release: Lineage Cell Therapeutics to Report Third Quarter 2026 Financial Results and Provide Business Update on November 12, 2026
Moomoo ·
- Lineage Cell Therapeutics to Report Third Qua
Moomoo ·
- Lineage Cell Therapeutics to Report Third Quarter 2026 Financial Results and Provide Business Update on November 12, 2026
Yahoo Finance ·
- Lineage Provides Update on ReSonance® Program for Hearing Loss
Yahoo Finance ·
- 3 Small Cap Stocks With Strong Revenue Growth And Low Debt
Yahoo Finance ·
- Lineage Cell Therapeutics Announces Issuance of Patent Underlying Its AlloSCOPE™ 5D Manufacturing Platform
Yahoo Finance ·
- Lineage Cell Therapeutics (LCTX) Q2 2026 Earnings Call Transcript
fool.com ·
- Lineage Cell Therapeutics Q2 Earnings Call Highlights
marketbeat.com ·
- Lineage Cell Therapeutics, Inc. Q2 2026 Earnings Call Summary
app.moby.co ·
- Lineage Cell Therapeutics Inc (LCTX) (Q2 2026) Earnings Call Highlights: Cash Runway Extended, ...
Yahoo Finance ·
Lineage Cell Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $14.6M | $9.5M | $8.9M | $14.7M |
| Net income | -$63.5M | -$18.6M | -$21.5M | -$26.3M |
| Diluted EPS | $-0.28 | $-0.09 | $-0.12 | $-0.15 |
| Total assets (year end) | $112.6M | $113.2M | $101.0M | $123.7M |
| Cash and equivalents (year end) | $40.8M | $45.8M | $35.4M | $11.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Lineage Cell Therapeutics, Inc.
- Ticker
- LCTX (NYSE)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Carlsbad, CA
- Incorporated in
- CA
- Fiscal year end
- December 31
- SEC CIK
- 876343
- Former names
- BIOTIME INC
Frequently asked questions
What exchange is Lineage Cell Therapeutics, Inc. listed on?
Lineage Cell Therapeutics, Inc. trades on the NYSE under the ticker symbol LCTX.
What industry is Lineage Cell Therapeutics, Inc. in?
Lineage Cell Therapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Lineage Cell Therapeutics, Inc. headquartered?
Lineage Cell Therapeutics, Inc.'s business address on file with the SEC is in Carlsbad, CA.
When does Lineage Cell Therapeutics, Inc.'s fiscal year end?
Lineage Cell Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Lineage Cell Therapeutics, Inc. report?
Lineage Cell Therapeutics, Inc. reported $14.6M in revenue for calendar year 2025, according to its SEC filings.